# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5105424 | B | Inhibition of recombinant human TG2 expressed in Escherichia coli assessed as Kinact using Cbz-Glu(gamma-p-nitrophenyl ester)Gly (AL5) as substrate by colorimetric assay | Homo sapiens | 16 | ALA5104118 | assay format | Scientific Literature | |
2. | ALA5105425 | B | Inhibition of recombinant human TG2 expressed in Escherichia coli assessed as inhibition constant using Cbz-Glu(gamma-p-nitrophenyl ester)Gly (AL5) as substrate by colorimetric assay | Homo sapiens | 16 | ALA5104118 | assay format | Scientific Literature | |
3. | ALA5105426 | B | Inhibition of recombinant human TG2 expressed in Escherichia coli assessed as Kinact/Ki ratio using Cbz-Glu(gamma-p-nitrophenyl ester)Gly (AL5) as substrate by colorimetric assay | Homo sapiens | 16 | ALA5104118 | assay format | Scientific Literature | |
4. | ALA5105427 | B | Inhibition of GTP binding to recombinant human TG2 expressed in Escherichia coli incubated for 30 mins by GTP-gamma-S BODIPY assay | Homo sapiens | 4 | ALA5104118 | assay format | Scientific Literature | |
5. | ALA5233078 | B | Inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring Kinact incubated for 20 mins by colorimetric analysis | Homo sapiens | 12 | ALA5230175 | assay format | Scientific Literature | |
6. | ALA5233079 | A | Metabolic stability in pooled cryopreserved human hepatocytes assessed as half-life at 1 uM measured upto 120 mins by LC-MS/MS analysis | Homo sapiens | 3 | ALA5230175 | cell-based format | Scientific Literature | |
7. | ALA5233080 | A | Metabolic stability in human whole blood assessed as half-life at 1 to 5 uM measured upto 120 mins by LC-MS/MS analysis | Homo sapiens | 3 | ALA5230175 | tissue-based format | Scientific Literature | |
8. | ALA5233081 | A | Metabolic stability in human whole blood assessed as drug degradation measured upto 120 mins by LC-MS/ms analysis | Homo sapiens | 2 | ALA5230175 | tissue-based format | Scientific Literature | |
9. | ALA5233084 | B | Irreversible inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring KI incubated for 20 mins by colorimetric analysis | Homo sapiens | 12 | ALA5230175 | assay format | Scientific Literature | |
10. | ALA5233088 | B | Irreversible inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring Kinact/Ki ratio incubated for 20 mins by colorimetric analysis | Homo sapiens | 11 | ALA5230175 | assay format | Scientific Literature | |
11. | ALA5233090 | B | Irreversible inhibition of human recombinant tissue transglutaminase expressed in Escherichia coli using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring Kinact/Ki ratio by linear regression analysis | Homo sapiens | 11 | ALA5230175 | assay format | Scientific Literature | |
12. | ALA5233092 | P | GSH reactivity in aqueous buffer assessed as GSH adduct formation by measuring corrected intrinsic second order rate constant (K2 corrected) by HPLC analysis | 3 | ALA5230175 | small-molecule physicochemical format | Scientific Literature | ||
13. | ALA5233093 | B | Irreversible inhibition of human TG2 using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring observed binding constant incubated for 20 mins by colorimetric assay | Homo sapiens | 4 | ALA5230175 | single protein format | Scientific Literature | |
14. | ALA5233094 | B | Irreversible inhibition of human TG1 using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring observed binding constant incubated for 100 mins by colorimetric assay | Homo sapiens | 4 | ALA5230175 | single protein format | Scientific Literature | |
15. | ALA5233095 | B | Irreversible inhibition of human TG6 using Cbz-Glu-(gamma-p-nitrophenylester)Gly (AL5) as substrate assessed as substrate hydrolysis by measuring observed binding constant incubated for 60 mins by colorimetric assay | Homo sapiens | 4 | ALA5230175 | single protein format | Scientific Literature | |
16. | ALA5233096 | B | Reversible inhibition of activated human TG3 using peptidic FRET-quenched probe A101 as substrate by fluorescence based assay relative to control | Homo sapiens | 4 | ALA5230175 | single protein format | Scientific Literature | |
17. | ALA5233097 | B | Irreversible inhibition of human factor XIIIa using peptidic FRET-quenched probe A101 as substrate assessed as observed binding constant by fluorescence based assay | Homo sapiens | 3 | ALA5230175 | single protein format | Scientific Literature | |
18. | ALA5233099 | B | Selectivity index, ratio of observed binding constant for irreversible inhibition of human TG2 to observed binding constant for irreversible inhibition of human TG1 | Homo sapiens | 1 | ALA5230175 | assay format | Scientific Literature | |
19. | ALA5233100 | B | Selectivity index, ratio of observed binding constant for irreversible inhibition of human TG2 to observed binding constant for irreversible inhibition of human TG6 | Homo sapiens | 1 | ALA5230175 | assay format | Scientific Literature | |
20. | ALA5233101 | P | Ratio of Kinact/Ki for inhibition of human tissue transglutaminase assessed as substrate hydrolysis to corrected second order rate constant (K2 corrected) for GSH reactivity in aqueous buffer assessed as GSH adduct formation | 3 | ALA5230175 | small-molecule physicochemical format | Scientific Literature |